IN8bio
INAB
12 hedge funds and large institutions have $1.83M invested in IN8bio in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 17 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
28.05% more ownership
Funds ownership: 0.89% → 28.93% (+28%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
49% less capital invested
Capital invested by funds: $3.6M → $1.83M (-$1.77M)
57% less funds holding
Funds holding: 28 → 12 (-16)
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$413K |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$335K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$53.5K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$11.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$116K |
| 2 |
SIG
Stonegate Investment Group
Birmingham,
Alabama
|
-$29.9K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$15.5K |
| 4 |
State Street
Boston,
Massachusetts
|
-$14.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$11.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
HighTower Advisors
Chicago,
Illinois
| – | -$1.66K | -333 | Closed |
|
|
WIM
27
Westside Investment Management
Santa Monica,
California
| – | -$332 | -67 | Closed |
|
|
SS
28
SBI Securities
Tokyo,
Japan
| – | -$167 | -34 | Closed |
|
29
JP Morgan Chase
New York
| – | -$17 | -3 | Closed |
|
INAB Hedge Fund Activity: Q2 2025 in Review
12 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q2 2025, worth a combined $1.83M — down 49% from $3.6M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of INAB and 1 opened new positions — a net loss of 16 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was AIGH Capital Management, adding an estimated $413K. The largest seller was Sigma Planning Corp, exiting entirely with an estimated $116K sold.
- 12 institutional investors held IN8bio (INAB) as of Q2 2025, down from 28 in Q1 2025.
- Funds reported $1.83M of IN8bio stock for Q2 2025, down 49% quarter-over-quarter.
- 1 fund opened new IN8bio positions in Q2 2025 and 17 closed out, a net change of -16 holders.
- The largest IN8bio buyer in Q2 2025 was AIGH Capital Management, an estimated $413K added.
- The largest IN8bio seller in Q2 2025 was Sigma Planning Corp, an estimated $116K sold.
Based on aggregated 13F filings for Q2 2025.